Hypercholesterolemia and prostate cancer: A hospital-based case-control study

Cancer Causes and Control

Volumn 19, Issue 10, 2008, Pages 1259-1266

  Magura, Lindsay ^a   Blanchard, Richelle ^a   Hope, Brian ^a   Beal, James R ^a   Schwartz, Gary G ^b   Sahmoun, Abe E ^c  

^a UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c UND School of Medicine & Health Sciences Southeast Campus   (United States)

Author keywords

Epidemiology; Hypercholesterolemia; Lipid profiles; Prostate cancer; Statins

Indexed keywords

ATORVASTATIN; CHOLESTEROL; FLUINDOSTATIN; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; MULTIVITAMIN; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

ADULT; AGED; ARTICLE; BODY MASS; CANCER INCIDENCE; CANCER RISK; CANCER SUSCEPTIBILITY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DRUG USE; FAMILY HISTORY; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RISK REDUCTION; UNITED STATES; VITAMIN SUPPLEMENTATION;

AGED; BODY MASS INDEX; CASE-CONTROL STUDIES; CHOLESTEROL, LDL; CONFIDENCE INTERVALS; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; FAMILY HEALTH; HOSPITALS; HUMANS; HYPERCHOLESTEROLEMIA; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PREVALENCE; PROSTATIC NEOPLASMS; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; SMOKING; VITAMINS;

EID: 55849083093     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-008-9197-7     Document Type: Article

References (51)

1. A Jemal R Siegel E Ward 2008 Cancer Statistics CA Cancer J Clin 58 2 73
2. B Cox MJ Sneyd C Paul 2002 Vasectomy and the risk of prostate cancer JAMA 287 3110 3115 10.1001/jama.287.23.3110
3. LK Dennis DV Dawson 2002 Meta-analysis of measures of sexual activity and prostate cancer Epidemiology 13 72 79 10.1097/00001648-200201000-00012
4. VA Kirsh RB Hayes ST Mayne 2006 Supplemental and dietary vitamin E, beta-carotene, and vitamin C intakes and prostate cancer risk J Natl Cancer Inst 98 245 254
5. C Chen SK Lewis L Voigt 2005 Prostate carcinoma incidence in relation to prediagnostic circulating levels of insulin-like growth factor I, insulin-like growth factor binding protein 3, and insulin Cancer 103 76 84 10.1002/cncr.20727
6. E Giovannucci EB Rimm Y Liu 2003 Body mass index and risk of prostate cancer in U.S. health professionals J Natl Cancer Inst 95 1240 1244
7. G Swyer 1942 The cholesterol content of normal and enlarged prostates Cancer Res 2 372 375
8. Y Homma Y Kondo M Kaneko 2004 Promotion of carcinogenesis and oxidative stress by dietary cholesterol in rat prostate Carcinogenesis 25 6 1011 1014 10.1093/carcin/bgh105
9. U Sivaprasad T Abbas A Dutta 2006 Differential efficacy of 3-hydroxy-3-methylglutaryl CoA reductase inhibitors on the cell cycle of prostate cancer cells Mol Cancer Ther 5 9 2310 2316 10.1158/1535-7163.MCT-06- 0175
10. MA Shibata C Kavanaugh E Shibata 2003 Comparative effects of lovastatin on mammary and prostate oncogenesis in transgenic mouse models Carcinogenesis 24 3 453 459 10.1093/carcin/24.3.453
11. MR Graaf AB Beiderbeck AC Egberts DJ Richel HJ Guchelaar 2004 The risk of cancer in users of statins J Clin Oncol 22 12 2388 2394 10.1200/JCO.2004.02.027
12. F Bravi L Scotti C Bosetti 2006 Self-reported history of hypercholesterolaemia and gallstones and the risk of prostate cancer Ann Oncol 17 6 1014 1017 10.1093/annonc/mdl080
13. RA Hiatt BH Fireman 1986 Serum cholesterol and the incidence of cancer in a large cohort J Chronic Dis 39 11 861 870 10.1016/0021-9681(86)90034-2
14. P Knekt A Reunanen A Aromaa M Heliovaara T Hakulinen M Hakama 1988 Serum cholesterol and risk of cancer in a cohort of 39,000 men and women J Clin Epidemiol 41 6 519 530 10.1016/0895-4356(88)90056-X
15. GD Smith MJ Shipley MG Marmot G Rose 1992 Plasma cholesterol concentration and mortality. The Whitehall Study JAMA 267 1 70 76 10.1001/jama.267.1.70
16. E Jacobs C Rodriguez EB Bain Y Wang M Thun E Calle 2007 Cholesterol lowering drugs and advanced prostate cancer incidence in a large United States cohort Cancer Epidemiol Biomarkers Prev 16 2213 2217 10.1158/1055-9965.EPI-07- 0448
17. E Flick L Habel A Chan 2007 Statin use and risk of prostate cancer in the California Men's Health Study cohort Cancer Epidemiol Biomarkers Prev 16 2218 2225 10.1158/1055-9965.EPI-07-0197
18. T Murtola TLJ Tammela J Lahtela A Auvinen 2007 Cholesterol-lowering drugs and prostate cancer risk: a population-based case-control study Cancer Epidemiol Biomarkers Prev 16 2226 2232 10.1158/1055-9965.EPI-07-0599
19. EA Platz MF Leitzmann K Visvanathan 2006 Statin drugs and risk of advanced prostate cancer J Natl Cancer Inst 98 1819 1825
20. J Shannon S Tewoderos M Garzotto 2005 Statins and prostate cancer risk: a case-control study Am J Epidemiol 162 4 318 325 10.1093/aje/kwi203
21. TJ Murtola TL Tammela J Lahtela A Auvinen 2007 Cholesterol-lowering drugs and prostate cancer risk: a population-based case-control study Cancer Epidemiol Biomarkers Prev 16 2226 2232 10.1158/1055-9965.EPI-07-0599
22. S Bonovas K Filioussi NM Sitaras 2008 Statin use and the risk of prostate cancer: a meta-analysis of 6 randomized clinical trials and 13 observational studies Int J Cancer 123 899 904 10.1002/ijc.23550
23. Third Report of the National Cholesterol Education Program (NCEP) 2002 Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) Circulation 106 3143
24. DM Boudreau O Yu DL Miglioretti DS Buist SR Heckbert JR Daling 2007 Statin use and breast cancer risk in a large population-based setting Cancer Epidemiol Biomarkers Prev 16 3 416 421 10.1158/1055-9965.EPI-06-0737
25. M Sonnleithner K Jeschke L Bayer 2003 Dyslipoproteinemia as a risk factor in prostate cancer J Urol 169 4 76
26. JA Laukkanen DE Laaksonen L Niskanen E Pukkala A Hakkarainen JT Salonen 2004 Metabolic syndrome and the risk of prostate cancer in Finnish men: a population-based study Cancer Epidemiol Biomarkers Prev 13 10 1646 1650
27. J Hammarsten B Hogstedt 2004 Clinical, haemodynamic, anthropometric, metabolic and insulin profile of men with high-stage and high-grade clinical prostate cancer Blood Press 13 1 47 55 10.1080/08037050310025735
28. P Tuohimaa L Tenkanen H Syvala 2007 Interaction of factors related to the metabolic syndrome and vitamin D on risk of prostate cancer Cancer Epidemiol Biomarkers Prev 16 2 302 307 10.1158/1055-9965.EPI-06-0777
29. E Hamalainen H Adlercreutz C Ehnholm P Puska 1986 Relationships of serum lipoproteins and apoproteins to sex hormones and to the binding capacity of sex hormone binding globulin in healthy Finnish men Metabolism 35 6 535 541 10.1016/0026-0495(86)90011-9
30. SM Haffner RA Valdez 1995 Endogenous sex hormones: impact on lipids, lipoproteins, and insulin Am J Med 98 1A 40S 47S 10.1016/S0002-9343(99)80058-8
31. N Shono S Kumagai Y Higaki M Nishizumi H Sasaki 1996 The relationships of testosterone, estradiol, dehydroepiandrosterone-sulfate and sex hormone-binding globulin to lipid and glucose metabolism in healthy men J Atheroscler Thromb 3 1 45 51
32. J Hammarsten B Hogstedt 2004 Clinical, haemodynamic, anthropometric, metabolic and insulin profile of men with high-stage and high-grade clinical prostate cancer Blood Press 13 1 47 55 10.1080/08037050310025735
33. TJ Key N Allen P Appleby 2004 Fruits and vegetables and prostate cancer: no association among 1,104 cases in a prospective study of 130,544 men in the European Prospective Investigation into Cancer and Nutrition (EPIC) Int J Cancer 109 1 119 124 10.1002/ijc.11671
34. DO Stram JH Hankin LR Wilkens 2006 Prostate cancer incidence and intake of fruits, vegetables and related micronutrients: the multiethnic cohort study Cancer Causes Control 17 9 1193 1207 10.1007/s10552-006-0064-0
35. JL Colli A Colli 2006 International comparisons of prostate cancer mortality rates with dietary practices and sunlight levels Urol Oncol 24 3 184 194 10.1016/j.urolonc.2005.05.023
36. JH Cohen AR Kristal JL Stanford 2000 Fruit and vegetable intakes and prostate cancer risk J Natl Cancer Inst 92 1 61 68 10.1093/jnci/92.1.61
37. L Jian CJ Du AH Lee CW Binns 2005 Do dietary lycopene and other carotenoids protect against prostate cancer? Int J Cancer 113 6 1010 1014 10.1002/ijc.20667
38. KA Lawson ME Wright A Subar 2007 Multivitamin use and risk of prostate cancer in the National Institutes of Health-AARP Diet and Health Study J Natl Cancer Inst 99 10 754 764 10.1093/jnci/djk177
39. VL Stevens ML McCullough WR Diver 2005 Use of multivitamins and prostate cancer mortality in a large cohort of US men Cancer Causes Control 16 6 643 650 10.1007/s10552-005-0384-5
40. Centers for Disease Control and Prevention: Behavioral Risk Factor Surveillance System [ www.cdc.gov/brfss ]
41. GG Schwartz 2005 Vitamin D and the epidemiology of prostate cancer Semin Dial 18 276 289 10.1111/j.1525-139X.2005.18403.x
42. AR Kristal JL Stanford JH Cohen K Wicklund RE Patterson 1999 Vitamin and mineral supplement use is associated with reduced risk of prostate cancer Cancer Epidemiol Biomarkers Prev 8 10 887 892
43. G Drasch J Schopfer GN Schrauzer 2005 Selenium/cadmium ratios in human prostates: indicators of prostate cancer risk of smokers and nonsmokers, and relevance to the cancer protective effects of selenium Biol Trace Elem Res 103 2 103 107 10.1385/BTER:103:2:103
44. TE Rohan TG Hislop GR Howe RP Gallagher CZ Teh P Ghadirian 1997 Cigarette smoking and risk of prostate cancer: a population-based case-control study in Ontario and British Columbia, Canada Eur J Cancer Prev 6 4 382 388 10.1097/00008469-199708000-00011
45. V Singal V Khurana G Caldito C Fort 2005 Statins and prostate cancer risk: a large case-control study in Veterans J Clin Oncol 23 107S
46. SA Kaplan AG Meehan A Shah 2006 The age related decrease in testosterone is significantly exacerbated in obese men with the metabolic syndrome. What are the implications for the relatively high incidence of erectile dysfunction observed in these men? J Urol 176 4 Pt 1 1524 1527 10.1016/j.juro.2006.06.003
47. CY Young BT Montgomery PE Andrews SD Qui DL Bilhartz DJ Tindall 1991 Hormonal regulation of prostate-specific antigen messenger RNA in human prostatic adenocarcinoma cell line LNCaP Cancer Res 51 14 3748 3752
48. http://apps.nccd.cdc.gov/brfss/sex.asp?cat=CA&yr=2005&qkey= 4392&state=ND. Accessed on 21 May 2007
49. http://apps.nccd.cdc.gov/BRFSS/page.asp?cat=XX&yr=2007&state= ND#XX. Accessed on 11 May 2008
50. G Cinci R Pagani ML Pandolfi B Porcelli M Pizzichini E Marinello 1993 Effects of testosterone on cholesterol levels and fatty acid composition in the rat Life Sci 53 2 91 97 10.1016/0024-3205(93)90655-M
51. S Moorjani A Dupont F Labrie 1988 Changes in plasma lipoproteins during various androgen suppression therapies in men with prostatic carcinoma: effects of orchiectomy, estrogen, and combination treatment with luteinizing hormone-releasing hormone agonist and flutamide J Clin Endocrinol Metab 66 2 314 322